Danaher Corporation (DHR)
NYSE: DHR · IEX Real-Time Price · USD
246.58
+0.78 (0.32%)
At close: Apr 26, 2024, 4:00 PM
246.02
-0.56 (-0.23%)
After-hours: Apr 26, 2024, 7:40 PM EDT
Danaher Employees
Danaher had 63,000 employees on December 31, 2023. The number of employees decreased by 18,000 or -22.22% compared to the previous year.
Employees
63,000
Change (1Y)
-18,000
Growth (1Y)
-22.22%
Revenue / Employee
$357,444
Profits / Employee
$69,873
Market Cap
182.64B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 63,000 | -18,000 | -22.22% |
Dec 31, 2022 | 81,000 | 1,000 | 1.25% |
Dec 31, 2021 | 80,000 | 11,000 | 15.94% |
Dec 31, 2020 | 69,000 | 9,000 | 15.00% |
Dec 31, 2019 | 60,000 | -11,000 | -15.49% |
Dec 31, 2018 | 71,000 | 4,000 | 5.97% |
Dec 31, 2017 | 67,000 | 5,000 | 8.06% |
Dec 31, 2016 | 62,000 | -19,000 | -23.46% |
Dec 31, 2015 | 81,000 | 10,000 | 14.08% |
Dec 31, 2014 | 71,000 | 5,000 | 7.58% |
Dec 31, 2013 | 66,000 | 3,000 | 4.76% |
Dec 31, 2012 | 63,000 | 4,000 | 6.78% |
Dec 31, 2011 | 59,000 | 10,800 | 22.41% |
Dec 31, 2010 | 48,200 | 1,600 | 3.43% |
Dec 31, 2009 | 46,600 | -3,700 | -7.36% |
Dec 31, 2008 | 50,300 | 300 | 0.60% |
Dec 31, 2007 | 50,000 | 5,000 | 11.11% |
Dec 31, 2006 | 45,000 | 5,000 | 12.50% |
Dec 31, 2005 | 40,000 | 5,000 | 14.29% |
Dec 31, 2004 | 35,000 | 5,000 | 16.67% |
Dec 31, 2003 | 30,000 | 1,000 | 3.45% |
Dec 31, 2002 | 29,000 | 6,000 | 26.09% |
Dec 31, 2001 | 23,000 | -1,000 | -4.17% |
Dec 31, 2000 | 24,000 | 5,000 | 26.32% |
Dec 31, 1999 | 19,000 | 1,000 | 5.56% |
Dec 31, 1998 | 18,000 | 4,800 | 36.36% |
Dec 31, 1997 | 13,200 | 1,600 | 13.79% |
Dec 31, 1996 | 11,600 | 1,100 | 10.48% |
Dec 31, 1995 | 10,500 | 540 | 5.42% |
Dec 31, 1994 | 9,960 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
Thermo Fisher | 122,000 |
Abbott Laboratories | 114,000 |
Elevance Health | 104,900 |
AstraZeneca | 89,900 |
Pfizer | 88,000 |
Novartis AG | 76,057 |
AbbVie | 50,000 |
Amgen | 26,700 |
DHR News
- 2 days ago - What Should You Do With Danaher Stock At $250 After Q1 Beat? - Forbes
- 5 days ago - Danaher Shrugs Off Outlook for Falling Sales - Barrons
- 5 days ago - Danaher beats quarterly estimates on strength in diagnostics business - Reuters
- 5 days ago - Danaher Reports First Quarter 2024 Results - PRNewsWire
- 5 weeks ago - Danaher Schedules First Quarter 2024 Earnings Conference Call - PRNewsWire
- 2 months ago - Danaher to Present at TD Cowen Health Care Conference - PRNewsWire
- 2 months ago - Danaher Commits to Set Science-Based, Net-Zero Greenhouse Gas Emission Reduction Targets - PRNewsWire
- 2 months ago - Danaher Announces Quarterly Dividend - PRNewsWire